Companies

Israeli neuro device company, HeadSense, which is developing a non-invasive neurological monitor focused initially on an intracranial pressure application, has announced it has secured necessary financing for its venture.

Echo Therapeutics, Inc., a company developing its non-invasive Symphony® CGM System as a needle-free, wireless continuous glucose monitoring system, has issued a mid-year update to its shareholders outlining the progress it has made this year, its upcoming key strategic priorities and milestones, and its efforts to conserve cash.

ArthroCare Corp. says it has completed the acquisition of intriguingly named sinus surgery specialist, ENTrigue Surgical, Inc., in an all … continue reading “ArthroCare Adds Sinus Surgery Devices With ENTrigue Surgical Acquisition”

Orthofix International N.V., in collaboration with the Musculoskeletal Transplant Foundation (MTF), has announced the full market release of Trinity® ELITE™ … continue reading “Orthofix Launches Trinity® ELITE™ Moldable Bone Graft”

Circulatory support specialist Thoratec Corporation, has acquired the DuraHeart® II ventricular assist system from Terumo Corporation for an upfront cash payment of $13 million. Together with potential future milestone payments this could end up at $43.5 million.

Covidien has completed the separation of its Pharmaceuticals business, which is now held by Mallinckrodt plc, a new independent company. Mallinckrodt will begin “regular way” trading on the New York Stock Exchange today under the symbol “MNK.”

C. R. Bard, Inc. has entered into an agreement to sell certain assets of its Electrophysiology division to Boston Scientific Corporation for $275 million in cash. The transaction is expected to close in 2013, subject to certain regulatory and customary closing conditions.

St. Jude Medical, Inc. has gained regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) and launch of the Accent MRI™ Pacemaker and the Tendril MRI™ lead.

Medtronic has recently issued four Field Safety Notices (FSN) related to the SynchroMed II and SynchroMed EL implantable drug pumps and accessories. These have been wrapped up into one Device Alert by the UK’s MHRA regulatory authority.

Cynosure, Inc., minimally invasive and non-invasive aesthetic device company, has completed its acquisition of Palomar Medical Technologies, Inc. in a move that it hopes will cement its place as one of the premier aesthetic laser and light-based companies.

Boston Scientific Corporation is launching a new family of pacemakers in Europe, which monitor respiration, adjust pacing accordingly, and support insight into the patient’s overall heart failure status.

Boston Scientific Corporation is trumpeting a poster presentation at this week’s EHRA EuroPace 2013 in Athens. Data suggests the company’s … continue reading “Poster Points To Lower Complications For Boston’s S-ICD® System Vs Transvenous ICD Leads”

Pacing and remote monitoring technology company Biotronik has announced the European market launch of its Ilesto 7 Series. Ilesto 7 … continue reading “EU Market Sees Launch Of World’s First MR Approved DF4 ICD/CRT-D System”

Medtronic, Inc. has announced the first patient enrollments in the U.S. Overnight Closed Loop Study, a key feasibility trial to begin the commercialization path for a third-generation, fully automated artificial pancreas system for people with diabetes.

St.Jude Medical, Inc. has received CE Mark approval of its next-generation quadripolar device, the Quadra Assura MP™ cardiac resynchronization therapy defibrillator.

Tom Dugan Joins SurgiQuest, Inc. as President and Chief Commercialization Officer (via PR Newswire) MILFORD Conn., June 20, 2013 /PRNewswire/ … continue reading “S&N Man Dugan Is SurgiQuest’s New President”